iFAST Diagnostics Ltd awarded UKCA mark
iFAST ONE reduces antimicrobial susceptibility test time to under 3 hours
17 Feb 2026
The iFAST ONE ultra-rapid antimicrobial susceptibility test (AST) system is now UKCA Certified for testing patient samples, direct from Gram negative bacteria blood cultures.
Clinicians in hospitals throughout Great Britain can now use data from iFAST Diagnostics to prescribe the most suitable antibiotics for individual patient infections, which will save thousands of lives, shorten hospital stays and help the fight against antimicrobial resistance (AMR).
The iFAST system can deliver high-throughput AST results to clinicians in under three hours, at costs comparable to the current standard of care, but up to two days faster. This enables clinicians to determine and prescribe the optimal antibiotic to the sickest patients, all within a single working shift.
Dr Toby King, CEO, iFAST Diagnostics Ltd, said, “We are super-excited to have achieved our UKCA mark. As we go to market, hospitals using our system will have access to AST results in under three hours, instead of 24–48 hours, massively improving the outcome for thousands of patients, especially in increasingly critical areas such as sepsis and multi-drug-resistant infections, all without increasing the overall cost of the testing. To have achieved this within three years of founding the company is astonishing – and testament to the ability, dedication, and hard work of our amazing founders Hywel Morgan and Daniel Spencer, and the entire iFAST team.”